Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers

Background Elevated high-sensitivity C-reactive protein (hsCRP) levels are known to be associated with a poor prognosis for cancer patients, but inadequate data exist regarding whether pre- or postoperative hsCRP levels have better predictive value after oncologic surgery. This study evaluated the a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2018-11, Vol.25 (12), p.3660-3666
Hauptverfasser: Oh, Tak Kyu, Choi, YoungRok, Oh, Ah-Young, Chung, Seung Hyun, Han, Sunghee, Ryu, Jung-Hee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3666
container_issue 12
container_start_page 3660
container_title Annals of surgical oncology
container_volume 25
creator Oh, Tak Kyu
Choi, YoungRok
Oh, Ah-Young
Chung, Seung Hyun
Han, Sunghee
Ryu, Jung-Hee
description Background Elevated high-sensitivity C-reactive protein (hsCRP) levels are known to be associated with a poor prognosis for cancer patients, but inadequate data exist regarding whether pre- or postoperative hsCRP levels have better predictive value after oncologic surgery. This study evaluated the associations between pre- and postoperative hsCRP levels and 90-day postoperative mortality among patients who underwent surgery for abdominal or thoracic cancers. Methods This retrospective cohort study included 7933 patients who underwent elective surgery between January 2010 and December 2016. Cox regression analysis and receiver operative characteristic curve analyses were used to evaluate the prognostic values of preoperative hsCRP (
doi_str_mv 10.1245/s10434-018-6734-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2099433053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2098881357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-ce805c0d6a7da4470edbe490aded032b022ed67176cf665d6c5c15c45540f4173</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS1ERX_gAdggS2zYGOz4J8lyNECLNKijtqwtx75pXWXiwXZGmmfhZXFmCkhIXflI97vnyucg9JbRj6wS8lNiVHBBKGuIqotoX6AzJosQqmEvi6aqIW2l5Ck6T-mRUlZzKl-hU15Uw1txhn4tOj_47CHh0ON1BILN6PA6pBy2EE32O8BX_v6B3MKYCrjzeY-X5AaMPczWMWTwI17BDoaEc5hNnLcZt5R8Nnv8PcRshnlr0WeI-HaK9xD3uA8RLzoXNn40w-Ho3UOIxnqLl2a0ENNrdNKbIcGbp_cC_fj65W55RVbXl9-WixWxvK4ysdBQaalTpnZGiJqC60C01DhwlFcdrSpwqma1sr1S0ikrLZNWSCloL0okF-jD0Xcbw88JUtYbnywMgxkhTElXtG0FL8nxgr7_D30MUywfOFBN0zAuZ0N2pGwMKUXo9Tb6jYl7zaiem9PH5nRpTs_N6bbsvHtynroNuL8bf6oqQHUEUhmNJcJ_p593_Q2veaQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2098881357</pqid></control><display><type>article</type><title>Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Oh, Tak Kyu ; Choi, YoungRok ; Oh, Ah-Young ; Chung, Seung Hyun ; Han, Sunghee ; Ryu, Jung-Hee</creator><creatorcontrib>Oh, Tak Kyu ; Choi, YoungRok ; Oh, Ah-Young ; Chung, Seung Hyun ; Han, Sunghee ; Ryu, Jung-Hee</creatorcontrib><description>Background Elevated high-sensitivity C-reactive protein (hsCRP) levels are known to be associated with a poor prognosis for cancer patients, but inadequate data exist regarding whether pre- or postoperative hsCRP levels have better predictive value after oncologic surgery. This study evaluated the associations between pre- and postoperative hsCRP levels and 90-day postoperative mortality among patients who underwent surgery for abdominal or thoracic cancers. Methods This retrospective cohort study included 7933 patients who underwent elective surgery between January 2010 and December 2016. Cox regression analysis and receiver operative characteristic curve analyses were used to evaluate the prognostic values of preoperative hsCRP (&lt; 1 month before surgery) and postoperative hsCRP (&lt; 3 days after surgery). Results For predicting 90-day mortality, the area under the receiver operating characteristic curve was significantly larger for preoperative hsCRP than for postoperative hsCRP [0.76; 95% confidence interval (CI) 0.71–0.81 vs 0.65 95% CI 0.57–0.72; P  &lt; 0.001]. The optimal cutoff values were 0.5 mg/dL for preoperative hsCRP and 9.7 mg/dL for postoperative hsCRP. Based on these cutoff values, increased risks of 90-day mortality were significantly associated with preoperative hsCRP levels higher than 0.5 mg/dL [hazard ratio (HR) 7.60; 95% CI 4.43–13.03; P  &lt; 0.001] and postoperative hsCRP levels higher than &gt; 9.7 mg/dL (HR 1.83; 95% CI 1.12–2.98; P  = 0.016). Conclusion Both elevated pre- and postoperative hsCRP levels were associated with increased risks of 90-day mortality after surgery for thoracic and abdominal cancer. However, preoperative hsCRP had better prognostic value than postoperative hsCRP.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-018-6734-9</identifier><identifier>PMID: 30178394</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abdomen ; Abdominal Neoplasms - blood ; Abdominal Neoplasms - mortality ; Abdominal Neoplasms - pathology ; Abdominal Neoplasms - surgery ; Biomarkers, Tumor - blood ; C-reactive protein ; C-Reactive Protein - analysis ; Cancer ; Female ; Follow-Up Studies ; Health risk assessment ; Humans ; Lung cancer ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Mortality ; Oncology ; Postoperative Complications ; Postoperative period ; Preoperative Care ; Prognosis ; Retrospective Studies ; ROC Curve ; Surgery ; Surgical Oncology ; Survival Rate ; Thoracic Neoplasms - blood ; Thoracic Neoplasms - mortality ; Thoracic Neoplasms - pathology ; Thoracic Neoplasms - surgery ; Thoracic Oncology ; Thorax</subject><ispartof>Annals of surgical oncology, 2018-11, Vol.25 (12), p.3660-3666</ispartof><rights>Society of Surgical Oncology 2018</rights><rights>Annals of Surgical Oncology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-ce805c0d6a7da4470edbe490aded032b022ed67176cf665d6c5c15c45540f4173</citedby><cites>FETCH-LOGICAL-c372t-ce805c0d6a7da4470edbe490aded032b022ed67176cf665d6c5c15c45540f4173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-018-6734-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-018-6734-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30178394$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oh, Tak Kyu</creatorcontrib><creatorcontrib>Choi, YoungRok</creatorcontrib><creatorcontrib>Oh, Ah-Young</creatorcontrib><creatorcontrib>Chung, Seung Hyun</creatorcontrib><creatorcontrib>Han, Sunghee</creatorcontrib><creatorcontrib>Ryu, Jung-Hee</creatorcontrib><title>Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Background Elevated high-sensitivity C-reactive protein (hsCRP) levels are known to be associated with a poor prognosis for cancer patients, but inadequate data exist regarding whether pre- or postoperative hsCRP levels have better predictive value after oncologic surgery. This study evaluated the associations between pre- and postoperative hsCRP levels and 90-day postoperative mortality among patients who underwent surgery for abdominal or thoracic cancers. Methods This retrospective cohort study included 7933 patients who underwent elective surgery between January 2010 and December 2016. Cox regression analysis and receiver operative characteristic curve analyses were used to evaluate the prognostic values of preoperative hsCRP (&lt; 1 month before surgery) and postoperative hsCRP (&lt; 3 days after surgery). Results For predicting 90-day mortality, the area under the receiver operating characteristic curve was significantly larger for preoperative hsCRP than for postoperative hsCRP [0.76; 95% confidence interval (CI) 0.71–0.81 vs 0.65 95% CI 0.57–0.72; P  &lt; 0.001]. The optimal cutoff values were 0.5 mg/dL for preoperative hsCRP and 9.7 mg/dL for postoperative hsCRP. Based on these cutoff values, increased risks of 90-day mortality were significantly associated with preoperative hsCRP levels higher than 0.5 mg/dL [hazard ratio (HR) 7.60; 95% CI 4.43–13.03; P  &lt; 0.001] and postoperative hsCRP levels higher than &gt; 9.7 mg/dL (HR 1.83; 95% CI 1.12–2.98; P  = 0.016). Conclusion Both elevated pre- and postoperative hsCRP levels were associated with increased risks of 90-day mortality after surgery for thoracic and abdominal cancer. However, preoperative hsCRP had better prognostic value than postoperative hsCRP.</description><subject>Abdomen</subject><subject>Abdominal Neoplasms - blood</subject><subject>Abdominal Neoplasms - mortality</subject><subject>Abdominal Neoplasms - pathology</subject><subject>Abdominal Neoplasms - surgery</subject><subject>Biomarkers, Tumor - blood</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - analysis</subject><subject>Cancer</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Health risk assessment</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Oncology</subject><subject>Postoperative Complications</subject><subject>Postoperative period</subject><subject>Preoperative Care</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>ROC Curve</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><subject>Thoracic Neoplasms - blood</subject><subject>Thoracic Neoplasms - mortality</subject><subject>Thoracic Neoplasms - pathology</subject><subject>Thoracic Neoplasms - surgery</subject><subject>Thoracic Oncology</subject><subject>Thorax</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kc1u1DAUhS1ERX_gAdggS2zYGOz4J8lyNECLNKijtqwtx75pXWXiwXZGmmfhZXFmCkhIXflI97vnyucg9JbRj6wS8lNiVHBBKGuIqotoX6AzJosQqmEvi6aqIW2l5Ck6T-mRUlZzKl-hU15Uw1txhn4tOj_47CHh0ON1BILN6PA6pBy2EE32O8BX_v6B3MKYCrjzeY-X5AaMPczWMWTwI17BDoaEc5hNnLcZt5R8Nnv8PcRshnlr0WeI-HaK9xD3uA8RLzoXNn40w-Ho3UOIxnqLl2a0ENNrdNKbIcGbp_cC_fj65W55RVbXl9-WixWxvK4ysdBQaalTpnZGiJqC60C01DhwlFcdrSpwqma1sr1S0ikrLZNWSCloL0okF-jD0Xcbw88JUtYbnywMgxkhTElXtG0FL8nxgr7_D30MUywfOFBN0zAuZ0N2pGwMKUXo9Tb6jYl7zaiem9PH5nRpTs_N6bbsvHtynroNuL8bf6oqQHUEUhmNJcJ_p593_Q2veaQw</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Oh, Tak Kyu</creator><creator>Choi, YoungRok</creator><creator>Oh, Ah-Young</creator><creator>Chung, Seung Hyun</creator><creator>Han, Sunghee</creator><creator>Ryu, Jung-Hee</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20181101</creationdate><title>Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers</title><author>Oh, Tak Kyu ; Choi, YoungRok ; Oh, Ah-Young ; Chung, Seung Hyun ; Han, Sunghee ; Ryu, Jung-Hee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-ce805c0d6a7da4470edbe490aded032b022ed67176cf665d6c5c15c45540f4173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abdomen</topic><topic>Abdominal Neoplasms - blood</topic><topic>Abdominal Neoplasms - mortality</topic><topic>Abdominal Neoplasms - pathology</topic><topic>Abdominal Neoplasms - surgery</topic><topic>Biomarkers, Tumor - blood</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - analysis</topic><topic>Cancer</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Health risk assessment</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Oncology</topic><topic>Postoperative Complications</topic><topic>Postoperative period</topic><topic>Preoperative Care</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>ROC Curve</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><topic>Thoracic Neoplasms - blood</topic><topic>Thoracic Neoplasms - mortality</topic><topic>Thoracic Neoplasms - pathology</topic><topic>Thoracic Neoplasms - surgery</topic><topic>Thoracic Oncology</topic><topic>Thorax</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oh, Tak Kyu</creatorcontrib><creatorcontrib>Choi, YoungRok</creatorcontrib><creatorcontrib>Oh, Ah-Young</creatorcontrib><creatorcontrib>Chung, Seung Hyun</creatorcontrib><creatorcontrib>Han, Sunghee</creatorcontrib><creatorcontrib>Ryu, Jung-Hee</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oh, Tak Kyu</au><au>Choi, YoungRok</au><au>Oh, Ah-Young</au><au>Chung, Seung Hyun</au><au>Han, Sunghee</au><au>Ryu, Jung-Hee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>25</volume><issue>12</issue><spage>3660</spage><epage>3666</epage><pages>3660-3666</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Background Elevated high-sensitivity C-reactive protein (hsCRP) levels are known to be associated with a poor prognosis for cancer patients, but inadequate data exist regarding whether pre- or postoperative hsCRP levels have better predictive value after oncologic surgery. This study evaluated the associations between pre- and postoperative hsCRP levels and 90-day postoperative mortality among patients who underwent surgery for abdominal or thoracic cancers. Methods This retrospective cohort study included 7933 patients who underwent elective surgery between January 2010 and December 2016. Cox regression analysis and receiver operative characteristic curve analyses were used to evaluate the prognostic values of preoperative hsCRP (&lt; 1 month before surgery) and postoperative hsCRP (&lt; 3 days after surgery). Results For predicting 90-day mortality, the area under the receiver operating characteristic curve was significantly larger for preoperative hsCRP than for postoperative hsCRP [0.76; 95% confidence interval (CI) 0.71–0.81 vs 0.65 95% CI 0.57–0.72; P  &lt; 0.001]. The optimal cutoff values were 0.5 mg/dL for preoperative hsCRP and 9.7 mg/dL for postoperative hsCRP. Based on these cutoff values, increased risks of 90-day mortality were significantly associated with preoperative hsCRP levels higher than 0.5 mg/dL [hazard ratio (HR) 7.60; 95% CI 4.43–13.03; P  &lt; 0.001] and postoperative hsCRP levels higher than &gt; 9.7 mg/dL (HR 1.83; 95% CI 1.12–2.98; P  = 0.016). Conclusion Both elevated pre- and postoperative hsCRP levels were associated with increased risks of 90-day mortality after surgery for thoracic and abdominal cancer. However, preoperative hsCRP had better prognostic value than postoperative hsCRP.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>30178394</pmid><doi>10.1245/s10434-018-6734-9</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2018-11, Vol.25 (12), p.3660-3666
issn 1068-9265
1534-4681
language eng
recordid cdi_proquest_miscellaneous_2099433053
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Abdomen
Abdominal Neoplasms - blood
Abdominal Neoplasms - mortality
Abdominal Neoplasms - pathology
Abdominal Neoplasms - surgery
Biomarkers, Tumor - blood
C-reactive protein
C-Reactive Protein - analysis
Cancer
Female
Follow-Up Studies
Health risk assessment
Humans
Lung cancer
Male
Medicine
Medicine & Public Health
Middle Aged
Mortality
Oncology
Postoperative Complications
Postoperative period
Preoperative Care
Prognosis
Retrospective Studies
ROC Curve
Surgery
Surgical Oncology
Survival Rate
Thoracic Neoplasms - blood
Thoracic Neoplasms - mortality
Thoracic Neoplasms - pathology
Thoracic Neoplasms - surgery
Thoracic Oncology
Thorax
title Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T14%3A06%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abilities%20of%20Pre-%20and%20Postoperative%20High-Sensitivity%20C-Reactive%20Protein%20Levels%20to%20Predict%2090-Day%20Mortality%20After%20Surgery%20for%20Abdominal%20and%20Thoracic%20Cancers&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Oh,%20Tak%20Kyu&rft.date=2018-11-01&rft.volume=25&rft.issue=12&rft.spage=3660&rft.epage=3666&rft.pages=3660-3666&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-018-6734-9&rft_dat=%3Cproquest_cross%3E2098881357%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2098881357&rft_id=info:pmid/30178394&rfr_iscdi=true